Welcome v. Amplity Inc.

CourtDistrict Court, W.D. Missouri
DecidedMarch 16, 2023
Docket4:22-cv-00830
StatusUnknown

This text of Welcome v. Amplity Inc. (Welcome v. Amplity Inc.) is published on Counsel Stack Legal Research, covering District Court, W.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Welcome v. Amplity Inc., (W.D. Mo. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MISSOURI WESTERN DIVISION EMILY WELCOME, CHARLOTTE ) GRAHOVAC, ) ) Plaintiffs, ) ) Case No. 4:22-cv-00830-RK v. ) ) AMPLITY INC., ) ) Defendant. ) ORDER Currently before the Court are two motions: First, Plaintiffs Emily Welcome and Charlotte Grahovac filed a motion to stay this case pending the Supreme Court’s anticipated decision in Groff v. DeJoy, No. 22-174 (U.S.). (Doc. 9.) Second, Defendant Amplity Inc. filed a motion to dismiss Counts I, II, and V of Plaintiffs’ complaint under Rule 12(b)(6) of the Federal Rules of Civil Procedure. (Doc. 13.) Both motions are unopposed as no party filed a response to the opposing party(ies)’s motion. After careful consideration and for the reasons explained below, the Court ORDERS that: (1) Amplity’s motion to dismiss (Doc. 13) is GRANTED in part and DENIED in part; and (2) Plaintiffs’ motion to stay (Doc. 9) is GRANTED. I. Background The following facts are taken from Plaintiffs’ complaint and are accepted as true for purposes of considering the two motions above. Plaintiffs Emily Welcome and Charlotte Grahovac worked at Amplity Inc. as Biosimilar Account Specialists. (Doc. 1 at ¶ 1.) Ms. Welcome began in August of 2018; Ms. Grahovac began in January 2020. Both were assigned to a customer, Organon, which sells immunology and oncology biosimilar products in the healthcare field. (Id.at ¶ 2.) At the time they began their employment, Plaintiffs were not required to disclose any immunity status and were not required to take any particular vaccines. (Id.) While Plaintiffs were employed at Amplity, Amplity advertised a position, “Immunology Specialty Representative,” for which “Proof of Covid Vaccination [is] Required.” (Id. at ¶ 1.) In addition, on October 5, 2021, Amplity enacted a policy requiring COVID-19 vaccination for its employees. (Id. at ¶ 80.) The policy set November 24, 2021, as a deadline for “Amplity field- based employees working on behalf of Organon” to comply with the new vaccination policy. (Id.) The policy required employees to be “fully vaccinated,” which was defined as “two weeks following the final dose of a COVID-19 vaccine that has received final approval by the U.S. Food and Drug Administration (FDA) and the World Health Organization.” (Id. at ¶ 22.) Amplity did not provide religious or medical accommodations to its COVID-19 vaccination requirement in the policy. (Id.) Organon instituted its own policy requiring its employees be fully vaccinated by November 24, 2021, which did include exemptions for medical and religious accommodations. (Id. at ¶ 81.) Ms. Welcome submitted a religious accommodation request to Amplity on November 8, 2021. (Id. at ¶ 17.) A few weeks later, Amplity rejected the request, stating “the Exemption Review Board does not believe this criteria [that her refusal to be vaccinated was based on a sincere belief that is religious in nature] was met.” (Id.) Amplity further explained that “even if your exemption request is approved, Amplity is not able to provide a reasonable accommodation for your current role. The Biosimilar Account Specialty role requires regular in-person engagements . . . in medical offices and facilities[.] . . . Engaging in these interactions unvaccinated and on behalf of the company puts you and the company at great risk.” (Id. at ¶ 18.) Ms. Grahovac, who also submitted a request based on asserted sincerely held religious beliefs, received an identical response from Amplity around the same time as Ms. Welcome. (Id. at ¶ 19.) After their religious accommodation requests were denied, Plaintiffs were both placed on unpaid leave effective December 1, 2021. (Id. at ¶ 25.) Amplity stopped paying Ms. Welcome on November 24, 2021, and converted her employment to unpaid-leave status on November 29, 2021. (Id.) Both Plaintiffs were provided “closeout information” in this interim period, and Amplity posted Ms. Grahovac’s position as “open.” (Id. at ¶¶ 27, 30 & 31.) Ms. Grahovac was ultimately terminated on December 10, 2021; Ms. Welcome was terminated on December 13, 2021. (Id. at ¶¶ 28 &30.) Plaintiffs were terminated because they failed to comply with Organon’s vaccination policy. (Id. at ¶ 21.) Although Organon’s policy provided for religious accommodations, Amplity did not provide Plaintiffs with an avenue to pursue a religious accommodation with Organon. (Id.) Ms. Welcome filed a charge of discrimination with the Missouri Commission on Human Rights, which issued a Notice of Right to Sue on November 2, 2022. (Id. at ¶¶ 48-49.) Ms. Grahovac similarly filed a charge of discrimination with the EEOC, which issued a Notice of Right to Sue on October 20, 2022. (Id. at ¶¶ 51-52.) Plaintiffs seek relief for employment and disability discrimination under various federal and state law claims, including: • Count I – failure to accommodate disability in violation of the Americans with Disabilities Act of 1990 and the Rehabilitation Act of 1973; • Count II – religious discrimination (disparate treatment) in violation of Title VII of the Civil Rights Act of 1964 (“Title VII”); • Count III – religious discrimination (failure to accommodate) in violation of Title VII; • Count IV – religious discrimination (retaliation) in violation of Title VII; • Count V – religious discrimination (disparate treatment) in violation of Title VII; • Count VI – religious discrimination in violation of the Missouri Human Rights Act (“MHRA”); and • Count VII – disability discrimination in violation of the MHRA. II. Defendant Amplity’s Motion to Dismiss Counts I, II, and V (Doc. 13) Amplity asserts that Counts I, II, and V of Plaintiff’s complaint must be dismissed under Rule 12(b)(6) of the Federal Rules of Civil Procedure for failure to state a claim. A. Legal Standard Under Rule 12(b)(6) of the Federal Rules of Civil Procedure, a party may move to dismiss a complaint for failure to state a claim for relief. In order to avoid dismissal under Rule 12(b)(6), a complaint must allege “enough facts to state a claim to relief that is plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 547 (2007). The plausibility pleading standard requires a showing of more than just a mere possibility that the relief sought is in fact obtainable. Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). When reviewing a 12(b)(6) motion to dismiss, the Court must accept the plaintiff’s specific factual allegations as true, but it is not obligated to accept as true the plaintiff’s legal conclusions. Brown v. Medtronic, Inc., 628 F.3d 451, 459 (8th Cir. 2010). B. Count I – ADA/Rehabilitation Act Disability Claim In Count I, Plaintiffs allege Amplity violated the ADA/Rehabilitation Act to the extent its “vaccine policy considers the plaintiffs’ medical condition of being ‘unvaccinated’ as a disability,” and then “terminated the plaintiffs because of [their] perceived disability constituting not having artificially induced immunities to the SARS virus.” (Doc. 1 at ¶¶ 110-11.) Amplity argues that Count I must be dismissed because Plaintiffs have not administratively exhausted this claim. The Court agrees. “Prior to filing a federal employment action in the district court a complainant must comply with certain notice and exhaustion requirements.” Coons v. Mineta, 410 F.3d 1036, 1039 (8th Cir. 2005).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Welcome v. Amplity Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/welcome-v-amplity-inc-mowd-2023.